NCT04741139 Post IVIG Medication in Children With Immune Thrombocytopenia Status UNKNOWN Phase PHASE1
NCT04737850 Hetrombopag for Pediatric Patients With Chronic Immune Thrombocytopenia Status COMPLETED Phase PHASE3
NCT04735588 Investigation on the Incidence and Course of COVID-19 in Patients With Prior, Ongoing or de Novo ITP. Evaluation of the Impact of COVID-19 Pandemic on the Management of ITP Status UNKNOWN Phase N/A
NCT04638829 Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim Status COMPLETED Phase PHASE4
NCT04588194 Romiplostim, Rituximab and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia Status UNKNOWN Phase PHASE2
NCT04562766 Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04518878 Fixed Low-dose Eltrombopag and rhTPO for Immune Thrombocytopenia (FLOWER) Status UNKNOWN Phase PHASE1
NCT04516967 Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months Status COMPLETED Phase PHASE3
NCT04516837 Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19) Status UNKNOWN Phase PHASE2
NCT04481282 The Combination of Terbutaline and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia Status UNKNOWN Phase PHASE2
NCT04368598 The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITP Status UNKNOWN Phase PHASE2
NCT04320225 Connection Between Vitamin D Level and the Efficacy of Dexamethasone in Immune Thrombocytopenia Status UNKNOWN Phase N/A
NCT04311593 Prognostic Value of CD Markers in Immune Thrombocytopenic Purpura Status UNKNOWN Phase N/A
NCT04289207 Phase II Trial of Romiplostim With Danazol in Patients With Eltrombopag-resistant Immune Thrombocytopenia Status UNKNOWN Phase PHASE2
NCT04217148 The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia Status COMPLETED Phase PHASE2
NCT04094805 A Multicenter Randomized Study of Vitamin D Combined With HD-DXM Versus HD-DXM for the Treatment of ITP Status UNKNOWN Phase PHASE4
NCT04056195 Study of Oral SKI-O-703, SYK Inhibitor, in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP) Status COMPLETED Phase PHASE2
NCT04039477 A Phase 2 Study to Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITP Status WITHDRAWN Phase PHASE2